Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Radicava
Pharma
Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma
After rumblings of a private equity bidding war last year, Bain Capital has emerged triumphant in its quest to acquire Mitsubishi Tanabe Pharma.
Fraiser Kansteiner
Feb 7, 2025 11:26am
Mitsubishi Tanabe models economic impact of IV-to-oral switch
Aug 2, 2022 7:40am
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
May 20, 2022 9:15am
Oral version of Mitsubishi's ALS drug Radicava gets FDA blessing
May 13, 2022 9:31am
Radicava stalls in EU as skeptical regulators demand new ALS trial
May 31, 2019 12:19pm
New Mitsubishi Tanabe tool finds ALS care centers for patients
May 22, 2019 9:22am
